Colorectal CancerNCT01904955
Should Colorectal Cancer Patients be Followed After Five Years? Study of Recurrence in a Population Cohort
An observational study of Colorectal Cancer, run by Centre Hospitalier Universitaire Dijon at 1 site in France.
Trial summary
The results of this study will make it possible, thanks to better understanding of the natural history of colorectal cancer, to define new treatment and surveillance strategies for colorectal cancers resected with curative intent, so as to improve management and thus improve patient survival. Read more about this study
- Who is it for?
- Any age
- Conditions the study is for
- Colorectal Cancer
- How many people
- 598 participants
- Where
- 1 siteFrance
- Study dates
- Sep 2010to Feb 2013
- How long will I take part?
- 1 Day
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- No healthy volunteers
- Child, Adult, Older adult
Study population: patients with adenocarcinoma of the colon or rectum
Who may be able to join
- with adenocarcinoma of the colon or rectum (ICD-O: C18, C19 and C20)
- residing in the département of Côte-d'Or (501,000 inhabitants according to the 1999 census) or Calvados (511, 012 inhabitants) at the moment of diagnosis
- recorded by either Registry between January 1985 and December 2000
- treated by resection with a curative intent.
Who cannot join
- Will be excluded other morphologic tumours and initially metastatic colorectal cancers, anal cancers.
Trial locations and contacts
1 site in 1 country.
About this study
The results of this study will make it possible, thanks to better understanding of the natural history of colorectal cancer, to define new treatment and surveillance strategies for colorectal cancers resected with curative intent, so as to improve management and thus improve patient survival.
These data will also make it possible to calculate the prevalence of patients who require treatment or surveillance because of their disease.
- Conditions
- Colorectal Cancer
- Medical subject headings
- Colorectal Neoplasms
What is being measured
The primary outcome is the main question the study is designed to answer.
data concerning evolving relapse
- the date of recurrence
- the site
- the finality of the surgical treatment (resection with curative intent defined as macroscopically complete resection, without involvement of the surgical margin in the histological examination)
- the non-surgical adjuvant or palliative treatments (radiotherapy, chemotherapy).
Measured: during the 10 years following resection for colorectal cancer with curative intent
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted22 Jul 2013 (estimated)
- Study startSep 2010
- Primary completionFeb 2013
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Colorectal CancerStudies of the same condition, open and under way.
- More trials run by Centre Hospitalier Universitaire DijonThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 598 participants (actual)
- Target duration
- 1 Day
Sponsor and investigators
- Lead sponsor
- Centre Hospitalier Universitaire Dijon
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- FAIVRE Jean, Principal investigator, CHU Dijon Gastroentérologie
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT01904955
- Sponsor's protocol ID
- Faivre PHRC K 2010
- Status last verified
- Mar 2026
- First submitted
- 8 Jul 2013
- Last updated
- 12 Mar 2026
- Results posted
- No
Publications
Cottet V, Bouvier V, Rollot F, Jooste V, Bedenne L, Faivre J, Launoy G, Bouvier AM. Incidence and patterns of late recurrences in rectal cancer patients. Ann Surg Oncol. 2015 Feb;22(2):520-7. doi: 10.1245/s10434-014-3990-1. Epub 2014 Aug 27.
PubMed 25160733
Study at a glance
From the registry record, last updated by the sponsor on 12 Mar 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Should Colorectal Cancer Patients be Followed After Five Years? Study of Recurrence in a Population Cohort
- ClinicalTrials.gov ID
- NCT01904955
- Acronym / sponsor ID
- Faivre PHRC K 2010
- Conditions
- Colorectal Cancer
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 598 participants (actual)
- Lead sponsor
- Centre Hospitalier Universitaire DijonUniversity, hospital or other
- Study start
- Sep 2010
- Primary completion
- Feb 2013 (actual)
- First posted
- 22 Jul 2013 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The results of this study will make it possible, thanks to better understanding of the natural history of colorectal cancer, to define new treatment and surveillance strategies for colorectal cancers resected with curative intent, so as to improve management and thus improve patient survival.
These data will also make it possible to calculate the prevalence of patients who require treatment or surveillance because of their disease.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Target follow-up
- 1 Day
Who may qualify
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult, Older adult
- Study population
- patients with adenocarcinoma of the colon or rectum
Key inclusion criteria (4 listed)
- with adenocarcinoma of the colon or rectum (ICD-O: C18, C19 and C20)
- residing in the département of Côte-d'Or (501,000 inhabitants according to the 1999 census) or Calvados (511, 012 inhabitants) at the moment of diagnosis
- recorded by either Registry between January 1985 and December 2000
- treated by resection with a curative intent.
Key exclusion criteria (1 listed)
- Will be excluded other morphologic tumours and initially metastatic colorectal cancers, anal cancers.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
data concerning evolving relapse
Time frame: during the 10 years following resection for colorectal cancer with curative intent
* the date of recurrence * the site * the finality of the surgical treatment (resection with curative intent defined as macroscopically complete resection, without involvement of the surgical margin in the histological examination) * the non-surgical adjuvant or palliative treatments (radiotherapy, chemotherapy).
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 12 Mar 2026.
- Results publication: PubMed 25160733Cottet V, Bouvier V, Rollot F, Jooste V, Bedenne L, Faivre J, Launoy G, Bouvier AM. Incidence and patterns of late recurrences in rectal cancer patients. Ann Surg Oncol. 2015 Feb;22(2):520-7. doi: 10.1245/s10434-014-3990-1. Epub 2014 Aug 27.
Related trials for Colorectal Cancer
Not yet recruitingPhase 1
Hepatic Artery Infusion of Carfilzomib in Participants With Liver Metastatic Disease Previously Treated With Hepatic Artery Infusion Pump Therapy
Colorectal Neoplasms, Neoplasms
Active, not recruiting
Streamlined Geriatric and Oncological Evaluation Based On IC Technology
Breast Cancer, Comorbidities and Coexisting Conditions
RecruitingObservational study
Pre- and On-treatment Multi-omics Profiling of Locally Advanced Rectal Cancer
Rectal Neoplasms
Enrolling by invitationObservational study
Natural History Study of Early Life Exposures in Agriculture (ELEA)
Prostate Cancer, Leukemia
RecruitingPhase 2
Tislelizumab in People With Colorectal Cancer
Colorectal Cancer
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
FAIVRE Jean principal investigator
CHU Dijon Gastroentérologie
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Colorectal Cancer, run by Centre Hospitalier Universitaire Dijon at 1 site in France.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 12 Mar 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
data concerning evolving relapse (time frame: during the 10 years following resection for colorectal cancer with curative intent). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT01904955, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Mar 2026.